Speaker Profile
M.D.,Ph.D., VP, Daiichi Sankyo
Biography
Gerold is Medical Oncologist and Hematologist with 17 years of academic background, including 3 years as a Research Fellow at the Dana-Farber Cancer Institute, and 20 years in oncology drug development in the pharmaceutical industry. He currently serves as Head of Early-Stage Oncology Team Leads at DSI. Prior to that, he was VP, Global Team Lead, responsible for the development of trastuzumab deruxtecan (DS-8201, ENHERTU). Prior to Daiichi Sankyo, Dr. Meinhardt served in different roles at Bayer Pharmaceuticals for more than 15 years, most notably as Vice President in Clinical Development leading the development of multikinase inhibitors sorafenib and regorafenib. Dr. Meinhardt has authored more than 60 PubMed-listed publications.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Okan Ekinci, Roche / Navify
PMWC Award Ceremony
• Fei-Fei Li, Stanford (Pioneer)
• Andrew Ng, Stanford / DeepLearning.AI (Luminary)
• Daphne Koller, insitro (Luminary)
Featured Speakers
• Fei-Fei Li, Stanford
• Andrew Ng, Stanford / DeepLearning.AI
• Daphne Koller, insitro
• Andy Beck, PathAI
• Germán Corredor Prada, Emory / Georgia Tech
• Drew Williamson, Emory
• Marina Sirota, UCSF
• Pranav Rajpurkar, Harvard
• Okan Ekinci, Roche / Navify
• Janusz Dutkowski, Data4Cure
• Alex Moreau, Champions Oncology
• Jadwiga Bienkowska, Pfizer
• Sharat Israni, UCSF
Beyond the Glass Slide
What computational pathology sees that humans cannot.
AI-Enabled Companion Diagnostics
From biomarker discovery to patient selection.
The Precision Oncology Operating System
Wiring multimodal AI into the oncology workflow.
AI and Omics Foundation Models
Modeling translational biology across omics, pathology, and clinical data.
From Pilot to Standard of Care
Scaling AI diagnostics in real clinical practice.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
